Serum ceruloplasmin and copper levels in patients with primary brain tumors.
Serum copper and ceruloplasmin levels are known to increase in several malignancies such as osteosarcomas, some gastrointestinal tumors, and lung cancer. In this study serum copper and ceruloplasmin levels in 40 patients with primary brain tumors were studied. Both parameters were increased in sera of patients with tumors in comparison with healthy subjects or patients with non-tumorous neurological diseases. It is concluded that copper and ceruloplasmin represent a good complement to some other nonspecific parameters in evaluating the activity of malignancy and the therapeutic results.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001254:Astrocytoma / Q000097:blood; D001932:Brain Neoplasms / Q000097:blood* / Q000473:pathology; D002528:Cerebellar Neoplasms / Q000097:blood; D002570:Ceruloplasmin / Q000378:metabolism*; D003300:Copper / Q000097:blood*; D004806:Ependymoma / Q000097:blood; D005260:Female; D005909:Glioblastoma / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009837:Oligodendroglioma / Q000097:blood
D003300:Copper; D002570:Ceruloplasmin